274
Participants
Start Date
May 25, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
July 31, 2025
BPI-16350
BPI-16350 400 mg, orally once daily
placebo
Placebo 400 mg, orally once daily
Fulvestrant
Fulvestrant 500 mg intramuscular injection on day 1 and day 15 for the first cycle and then on day 1 for every cycle until progressive disease
The First Hospital of China Medical University, Shenyang
The First Medical Center of the PLA General Hospital, Beijing
The Seventh Medical Center of the PLA General Hospital, Beijing
The First Affiliated Hospital of Gannan Medical College, Ganzhou
Shengjing Hospital of China Medical University, Shenyang
Liaoning Cancer Hospital & Institute, Shenyang
The Second Affiliated Hospital of Dalian Medical University, Dalian
Jilin Cancer Hospital, Changchun
The Second Hospital of Jilin University, Changchun
Jilin Hospital of Chinese Literature, Siping
Harbin Medical University Cancer Hospital, Harbin
Fudan University Shanghai Cancer Center, Shanghai
Jiangsu Cancer Hospital, Nanjing
The Second Affiliated Hospital of Soochow University, Suzhou
Xuzhou Central Hospital, Xuzhou
Anhui Provincial Hospital, Hefei
The First Affiliated Hospital of Anhui Medical University, Hefei
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Shandong Cancer Hospital, Jinan
Weifang People's Hospital, Weifang
Weihai Municipal Hospital, Weihai
The Affiliated Hospital of Qingdao University, Qingdao
Affiliated Hospital of Jining Medical University, Jining
Linyi Cancer Hospital, Linyi
Tianjin Cancer Hospital, Tianjin
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Zhejiang Provincial People's Hospital, Hangzhou
The First Affiliated Hospital of Nanchang University, Nanchang
The Third Hospital of Nanchang, Nanchang
Fujian Medical University Union Hospital, Fuzhou
Fujian Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Ximen
Chongqing University Three Gorges Hospital, Chongqing
Hunan Cancer Hospital, Changsha
Zhuzhou Central Hospital, Zhuzhou
The First People's Hospital Of Changde City, Changde
Loudi Central Hospital, Loudi
The First Affiliated Hospital of Nanhua University, Hengyang
Inner Mongolia People's Hospital, Hohhot
Shaoyang Central Hospital, Shaoyang
Chenzhou First People's Hospital, Chenzhou
Yongzhou Central Hospital, Yongzhou
The Central Hospital of Wuhan, Wuhan
Fifth Hospital in WuHan, Wuhan
Renmin Hospital of Wuhan University, Wuhan
Hubei Cancer Hospital, Wuhan
Yichang Central People's Hospital, Yichang
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Anyang Cancer Hospital, Anyang
The first Affiliated Hospital of Nanyang Medical College, Nanyang
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
Sun Yat-Sen University Cancer Hospital, Guangzhou
Cancer Hospital of Shantou University Medical College, Shantou
The First Affiliated Hospital of Guangxi Medical University, Nanning
Sichuan Cancer Hospital&Institute, Chengdu
The Sixth People's Hospital of Chengdu, Chengdu
Yunnan Cancer Hospital, Kunming
The First Hospital of Lanzhou University, Lanzhou
Cancer Hospital of Xinjiang Medical University, Ürümqi
Cangzhou Hospital of Integrated TCM-WM·Hebei, Cangzhou
Affiliated Hospital of Chengde Medical University, Chengde
Tangshan People's Hospital, Tangshan
Xingtai People's Hospital, Xingtai
Lead Sponsor
Betta Pharmaceuticals Co., Ltd.
INDUSTRY